Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04445701 · COMPLETED
Trial details
- NCT number
- NCT04445701
- Sponsor
- Arch Oncology
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-08-05
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.